Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study.

Auteurs

Wery AR, Salaroli A, Andreozzi F, Paesmans M, Dewispelaere L, Heimann P, Wittnebel S, Lewalle P

  • Date de publication

    Oktober 2024

  • Type

    Article

  • Tijdschrift

    Ann Hematol

  • Naam van de onderzoeker

    Heimann Pierre

  • Hôpital

    Hôpital Erasme

  • Dienst

    Hémato-oncologie moléculaire

  • PMID

    39365357

  • DOI

    10.1007/s00277-024-06017-y